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different de novo lesions in the same vessel within a distance enough to allow the
deployment of two non-overlapped stents and with similar morphological features.
Each lesion was treated with each drug-eluting stent in a randomized location. Patients
were evaluated at 12 months with an OFDI system. Off-line analysis of the continuous
cross-sections within the stented segment was performed at 1 mm intervals. The strut
apposition and neointimal coverage were assessed for each strut.
Results: A total of 30 patients were included (age 69±7 yrs, 33% diabetics, 60%
unstable angina, 40% stable angina). At 12 months 30 PES (length 18.1±8 mm and
diameter 2.57±0,3 mm) were examined analyzing 154±90 struts and 30 EES (length
16.4±5 mm and diameter 2.65±0,3 mm) analyzing 158±72 struts. The proportion of
non-covered struts was 1.5±2.9 % in PES and 0.8±1.3% in EES (p=0.2). The rate of
malapposition among non-covered struts was 58% in PES and 22.5% in EES
(p=0.0017) being the maximal malapposition area significantly larger with PES (0.6±
0.3 vs. 0.25± 0.2 mm2, p=0.001).
Conclusion: In very similar conditions, same patient, same artery and similar lesions
EES show a trend towards a greater degree of intimal coverage at one year follow up
compared to PES and a significant lower rate of malapposed non covered struts. These
findings suggest that very late thrombosis rate could be lower with EES as opposed to
PES.
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Background: Although histologic experimental studies have reported delayed
neointimal healing in overlap compared to non-overlap segments in drug-eluting stents
(DES), these observations have not been confirmed in human coronary arteries hitherto.
On the contrary, angiographic and optical coherence tomography (OCT) studies suggest
that DES overlap elicits rather an exaggerated than an incomplete neointimal reaction.
We compare the coverage of overlap vs. non-overlap segments of the same lesion in
DES using OCT and accounting for eventual heterogeneity of the effect.
Methods: OCT studies from 2 randomized trials (NCT00617084, NCT00389220)
comparing different drug-eluting stents were analyzed at 9-13 months follow-up.
Coverage of struts in overlapping segments was compared vs. the corresponding non-
overlapping segments of the same stents, using statistical pooled analysis.
Results: 178 stents implanted in 99 patients were finally analyzed: 38 sirolimus-eluting
(SES), 33 biolimus-eluting (BES), 57 everolimus-eluting (EES) and 50 zotarolimus-
eluting stents (ZES); 34120 struts. The risk-ratio for non-coverage was 2.35 (95% CI:
1.86 – 2.98) in overlapping vs. non-overlapping segments. Thickness of coverage in
overlaps was only 85% (95% CI: 81 – 90%) of the thickness in non-overlaps.
Significant heterogeneity of the effect was observed, especially pronounced in the
comparison of thickness of coverage (I2=90.31).
Conclusion: DES struts in overlapping segments are at higher risk of incomplete tissue
coverage and are covered by a thinner neointimal layer than the struts in the
corresponding non-overlapping distal and proximal segments of the same stents at 9-
13 months. Although an average greater neointimal inhibition is observed in overlaps,
the neointimal reaction is subjected to pronounced interindividual variations.
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Background: The aim of this study is to evaluate the impact of inflammatory status
and surrogate marker levels of cholesterol metabolism on plaque vulnerability.
Methods: This study designed to enroll 80 stable angina pectoris patients. Non-culprit
vessels with more than 25% diameter stenosis by visual estimation were imaged with
a 20 MHz phased-array intravascular ultrasound (VH-IVUS) catheter (motorized pull-
back system at 0.5 mm/s) and optical coherence tomography (OCT) wire (motorized
pull-back system at 1 mm/s and analyzed at 0.3mm interval). Definite-fibroatheroma
(D-FA) was defined as 1) percent necrotic core area >20% in contact with the lumen
in VH-IVUS; 2) percent plaque plus media cross-sectional area >40% in VH-IVUS;
3) fibrous cap thickness at the thinnest part <65μm in OCT.
Results: High-sensitivity C-reaction protein (hsCRP), low-density lipoprotein (LDL)
cholesterol, campesterol, and the ratio of campesterol to lathosterol were significantly
positive correlation with percent necrotic core volume (%NCV). On the other hand,
lathosterol was significantly negative correlation with %NCV (table). In subgroup
divided by the incidence of D-FA, hsCRP, campesterol, and the ratio of campesterol
to lathosterol were significantly lower in no D-FA group (515±270 vs.967±457 ng/ml;
p=0.004, 159.2±83.3 vs. 218.5±92.4 μg/100mg total cholestenol; p=0.01, 1.82±1.01
vs. 3.50±1.50; p<0.0001), however lathosterol was significantly higher (96.1±44.2 vs.
68.5±29.3 μg/100mg total cholestenol; p=0.007).
Correlation cholesterol synthesis and absorption with percent necrotic core
volume
Conclusion: Higher inflammatory status, enhanced absorption, and reduced synthesis
of cholesterol may be related to plaque vulnerability.
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Background: Slow flow or no re-flow phenomenon is mainly induced by distal
embolization during PCI and is associated with unfavorable long-term clinical
outcomes. Various imaging modalities have failed to detect high risk patients of distal
embolization for whom distal protection might be beneficial. The object of this study
is to examine the frequency of distal embolization using filter-type distal protection
device and to clarify the predicting factors of distal embolization.
Methods: Consecutive patients (n=98) with or without ACS who received PCI with
filter-type distal protection device (Filtrap) and successful angioscopic and VH-IVUS
examination of target lesion were prospectively enrolled. Presence of yellow plaque
and plaque rupture were evaluated by angioscopy; and tissue classification and plaque
burden were evaluated by VH-IVUS. Distal embolization was evaluated by the
pathological examination of collected material in the filter device.
Results: Distal embolizatioin of thrombus tended to be frequent in ACS than in non
ACS patients (81.03% vs. 65%, P=0.074). That of plaque debris was more frequent in
ACS than non-ACS patients (48.28% vs. 25%, P<0.05). Distal embolization of plaque
debris was more frequent in the patients with rupured plaque than in those without it
(85.7% vs. 12.3%, p<0.05), in the patients with yellow plaque than in those without it
(50.7% vs. 7.0%, P<0.05), and tended to be more frequent in the patients with large
(>75%) plaque burden than in those without it (46.3% vs. 29.5%, p=0.09). Remarkably,
94% of patients with ruptured plaque and large plaque burden had distal embolization
of plaque debris.
Conclusion: Distal embolization of plaque debris was detected frequently in the
patients with ruptured yellow plaque and large plaque burden. Using both anigoscopy
and VH-IVUS before procedure, we may predict distal embolization. Filter-type distal
protection device would be potentially beneficial for those high risk patients.
TCT-628
Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent
Implantation: A Dosimetric 3D-Intravascular Ultrasound Study
Hideki Kitahara1, Teruyoshi Kume1, Katsuhisa Waseda1, Kenji Sakamoto1, Ryotaro
Yamada1, Paul Yock1, Ian T Meredith2, Martin B Leon3, Laura Mauri4, Alan C
Yeung1, Peter J Fitzgerald1, Yasuhiro Honda1
1Stanford University, Stanford, CA; 2Monash Heart and Medical Centre, Clayton,
Australia; 3Columbia University Medical Center/New York Presbyterian Hospital,
New York, NY; 4Harvard Medical School, Boston, MA
Background: In drug-eluting stents, a fixed loading dose per metal area may result in
considerable variability in actual dose exposed to vessel wall due to differences in strut
spacing once expanded in varying sizes of lesions. This study aimed to evaluate
potential effects of different dose intensity, as estimated by 3D-IVUS dosimetry, on
vascular response after Resolute zotarolimus-eluting stent (ZES) implantation.
Methods: Serial (baseline and 8-9 mo) 3D-IVUS was performed in 121 lesions treated
with a single Resolute ZES. Neointimal obstruction was calculated as neointima/stent
volume. Cross sectional narrowing (CSN) was defined as neointima/stent area. In each
lesion, exposed dose intensity was calculated as known loading dose/measured stented
segment surface area at post-procedure. Lesions were divided into tertiles based on the
dose intensity.
Results: The exposed dose intensity ranged from 0.76 to 1.58 μg/mm2 (1.08±0.18
μg/mm2). The low dose group showed a trend toward slightly greater neointima.
However, neointimal obstruction, max CSN, neointimal thickness, vessel remodeling,
and the incidence of late incomplete stent apposition were not significantly different
among the 3 groups.
Conclusion: Detailed 3D-IVUS dosimetry revealed a significant lesion-to-lesion
variability in dose intensity exposed to vessel wall following Resolute ZES
implantation. However, Resolute appears to yield equally effective neointimal
suppression and no evidence of adverse local vessel response, regardless of the varying
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